| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 29.525 | 37.332 | 45.718 | 51.224 | 58.989 | 77.614 | 93.150 | 84.874 | 81.511 |
| Total Income - EUR | - | 29.525 | 37.332 | 45.718 | 51.224 | 58.989 | 77.614 | 93.150 | 84.874 | 81.511 |
| Total Expenses - EUR | - | 16.228 | 13.710 | 27.209 | 46.330 | 42.938 | 44.639 | 6.608 | 27.964 | 36.298 |
| Gross Profit/Loss - EUR | - | 13.297 | 23.622 | 18.509 | 4.893 | 16.051 | 32.974 | 86.542 | 56.910 | 45.213 |
| Net Profit/Loss - EUR | - | 13.002 | 23.249 | 18.052 | 4.381 | 15.461 | 32.198 | 85.611 | 56.061 | 42.768 |
| Employees | - | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 0 |
Check the financial reports for the company - Neurostar Clinic Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 725 | 592 | 45.697 | 24.956 | 3.941 | 0 | 0 | 0 | 0 |
| Current Assets | - | 13.618 | 24.545 | 16.503 | 24.507 | 55.496 | 97.631 | 156.305 | 17.524 | 14.837 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 1.455 | 2.000 | 3.799 | 6.105 | 939 | 3.097 | 6.894 | 6.182 | 76 |
| Cash | - | 12.162 | 22.546 | 12.704 | 18.402 | 54.557 | 94.534 | 149.411 | 11.342 | 1.694 |
| Shareholders Funds | - | 13.046 | 23.378 | 41.001 | 44.588 | 59.203 | 79.981 | 155.295 | 16.809 | 13.245 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 1.296 | 1.759 | 21.199 | 4.875 | 234 | 17.650 | 1.009 | 715 | 1.592 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Neurostar Clinic Srl